Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Idenix reports phase I/II clinical trial data for NM-283 as treatment of hepatitis C

May 20, 2004

Elan and Biogen Idec to file for approval of Antegren for Crohn's disease in Europe

May 20, 2004

Reduced esophageal motility found with baclofen in healthy volunteers

May 20, 2004

Evidence supports a better safety profile of viramidine in hepatitis C patients

May 20, 2004

Data support improved profile of cisapride analogue ATI-7505

May 20, 2004

TC-240312 reported to inhibit the production of IL-8 in the intestinal mucosa

May 19, 2004

Talnetant stimulates peristalsis without affecting normal intestinal motility

May 19, 2004

Benefits of the antioxidant tetrathiomolybdate in experimental colitis

May 19, 2004

Benitec gains ddRNAi-based therapeutic for HCV through Avocel acquisition

May 19, 2004

Protein Design Labs discontinues development of daclizumab for ulcerative colitis

May 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...